Completed OBSERVATIONAL NCT02403765

Diagnostic Tools for Parkinson's Disease

Realization of Diagnostic Tools for the Early Analysis of Parkinson's Disease Through the Identification of Genetic Risk Profiles

Sponsor: Neuromed IRCCS

Conditions Parkinson Disease

Updated 11 times since 2017 Last updated: Oct 31, 2019 Started: May 31, 2015 Primary completion: Oct 31, 2018 Completion: Oct 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Parkinson Disease and is currently completed. Neuromed IRCCS leads this study, which shows 11 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 6 earlier versions

Dec 2019 — Nov 2020 [monthly]

Completed

Status: Unknown Status → Completed
Jun 2018 — Dec 2019 [monthly]

Unknown Status
May 2018 — Jun 2018 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
Apr 2018 — May 2018 [monthly]

Not Yet Recruiting

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Not Yet Recruiting NA
Jan 2017 — Aug 2017 [monthly]

Not Yet Recruiting NA

First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Neuromed IRCCS

Data source: Neuromed IRCCS

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pozzilli, Italy